NCT03786419 2021-05-13A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural MesotheliomaHealth Pharma Professional ResearchPhase 2 Withdrawn
NCT02941601 2019-09-27A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 2 Withdrawn